IL105318A - History of 2,3-Dihydro-benzopuranol Process for their preparation and pharmaceutical preparations containing the same - Google Patents
History of 2,3-Dihydro-benzopuranol Process for their preparation and pharmaceutical preparations containing the sameInfo
- Publication number
- IL105318A IL105318A IL105318A IL10531893A IL105318A IL 105318 A IL105318 A IL 105318A IL 105318 A IL105318 A IL 105318A IL 10531893 A IL10531893 A IL 10531893A IL 105318 A IL105318 A IL 105318A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- dihydro
- benzofuran
- pentamethyl
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92400956 | 1992-04-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL105318A0 IL105318A0 (en) | 1993-08-18 |
| IL105318A true IL105318A (en) | 1998-04-05 |
Family
ID=8211646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL105318A IL105318A (en) | 1992-04-06 | 1993-04-05 | History of 2,3-Dihydro-benzopuranol Process for their preparation and pharmaceutical preparations containing the same |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0635009B1 (no) |
| JP (1) | JP3246741B2 (no) |
| KR (1) | KR950700895A (no) |
| AT (1) | ATE158287T1 (no) |
| AU (1) | AU670433B2 (no) |
| CA (1) | CA2132829C (no) |
| DE (1) | DE69314022T2 (no) |
| DK (1) | DK0635009T3 (no) |
| ES (1) | ES2110602T3 (no) |
| FI (1) | FI944655A0 (no) |
| GR (1) | GR3025577T3 (no) |
| HU (1) | HUT68926A (no) |
| IL (1) | IL105318A (no) |
| MX (1) | MX9301950A (no) |
| NO (1) | NO943726L (no) |
| NZ (1) | NZ251134A (no) |
| TW (1) | TW226371B (no) |
| WO (1) | WO1993020057A1 (no) |
| ZA (1) | ZA932327B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5510373A (en) * | 1992-04-06 | 1996-04-23 | Merrell Pharmaceuticals Inc. | Cardioprotective agents |
| US5545660A (en) * | 1992-04-07 | 1996-08-13 | Merrell Pharmaceuticals Inc. | Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans |
| TW393475B (en) * | 1992-10-16 | 2000-06-11 | Chugai Pharmaceutical Co Ltd | 4-alkoxyl-2,6-di-t-butyl phenol derivatives |
| IT1256264B (it) * | 1992-12-31 | 1995-11-29 | Lifegroup Spa | N-acilderivati di idrossiammine dotati di attivita' scavenger ed utilizzabili nelle patologie acute e croniche correlate a fenomeni di perossidazione ed infiammazione |
| KR19980702883A (ko) * | 1995-03-10 | 1998-08-05 | 스티븐엘.네스비트 | 2,3-디히드로-벤조푸라놀 유도체의 신규 제조 방법 |
| US6140309A (en) * | 1996-03-12 | 2000-10-31 | University Of South Florida | Vasoactive effects and free radical generation by β-amyloid peptides |
| KR20050065661A (ko) * | 2002-11-01 | 2005-06-29 | 비로파마 인코포레이티드 | 벤조푸란 화합물, 조성물 및 ｃ형 간염 바이러스 감염 및관련 질병의 치료 및 예방 방법 |
| CA2522051C (en) | 2003-04-14 | 2009-11-17 | Nippon Soda Co., Ltd. | Diamine derivative, production process therefor and antioxidant |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8704572D0 (en) * | 1987-02-26 | 1987-04-01 | Lundbeck & Co As H | Organic compounds |
| JP2855340B2 (ja) * | 1988-06-10 | 1999-02-10 | 武田薬品工業株式会社 | ２―置換クマラン誘導体 |
| IT1229482B (it) * | 1988-08-01 | 1991-09-03 | Foscama Biomed Chim Farma | Acidi (rs) 2 (2,3 diidro 5 idrossi 4,6,7 trimetilbenzofuranil) acetico e 2 (2,3 diidro 5 acilossi 4,6,7 trimetilbenzofuranil) acetici e loro esteri, utili come farmaci mucoregolatori ed antiischemici. |
| IT1231341B (it) * | 1989-08-18 | 1991-11-28 | Foscama Biomed Chim Farma | 2,3 diidro 5 ossi 4,6,7 trimetilbenzofurani 2 (rs) sostituiti, utili come farmaci antiossidanti con proprieta' mucoregolatrici e antiischemiche. |
| US4975457A (en) * | 1989-09-25 | 1990-12-04 | Merck & Co., Inc. | Trans 2,3-disubstituted-2,3-dihydro-5-hydroxy-benzofurans as inhibitors of leukotriene biosynthesis |
| IE68675B1 (en) * | 1990-11-01 | 1996-07-10 | Takeda Chemical Industries Ltd | Aminocoumaran derivatives their production and use |
-
1993
- 1993-03-10 HU HU9402864A patent/HUT68926A/hu unknown
- 1993-03-10 DK DK93907336.7T patent/DK0635009T3/da active
- 1993-03-10 CA CA002132829A patent/CA2132829C/en not_active Expired - Fee Related
- 1993-03-10 NZ NZ251134A patent/NZ251134A/en unknown
- 1993-03-10 JP JP51745293A patent/JP3246741B2/ja not_active Expired - Fee Related
- 1993-03-10 AU AU37976/93A patent/AU670433B2/en not_active Ceased
- 1993-03-10 WO PCT/US1993/002107 patent/WO1993020057A1/en active IP Right Grant
- 1993-03-10 DE DE69314022T patent/DE69314022T2/de not_active Expired - Fee Related
- 1993-03-10 AT AT93907336T patent/ATE158287T1/de not_active IP Right Cessation
- 1993-03-10 EP EP93907336A patent/EP0635009B1/en not_active Expired - Lifetime
- 1993-03-10 ES ES93907336T patent/ES2110602T3/es not_active Expired - Lifetime
- 1993-03-31 ZA ZA932327A patent/ZA932327B/xx unknown
- 1993-04-01 TW TW082102444A patent/TW226371B/zh active
- 1993-04-05 IL IL105318A patent/IL105318A/en not_active IP Right Cessation
- 1993-04-05 MX MX9301950A patent/MX9301950A/es unknown
-
1994
- 1994-10-05 KR KR1019940703513A patent/KR950700895A/ko not_active IP Right Cessation
- 1994-10-05 NO NO943726A patent/NO943726L/no unknown
- 1994-10-05 FI FI944655A patent/FI944655A0/fi unknown
-
1997
- 1997-12-03 GR GR970403227T patent/GR3025577T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2110602T3 (es) | 1998-02-16 |
| EP0635009B1 (en) | 1997-09-17 |
| MX9301950A (es) | 1993-10-01 |
| FI944655A (fi) | 1994-10-05 |
| ATE158287T1 (de) | 1997-10-15 |
| NO943726L (no) | 1994-12-06 |
| TW226371B (no) | 1994-07-11 |
| CA2132829A1 (en) | 1993-10-14 |
| GR3025577T3 (en) | 1998-03-31 |
| JP3246741B2 (ja) | 2002-01-15 |
| AU670433B2 (en) | 1996-07-18 |
| HUT68926A (en) | 1995-08-28 |
| KR950700895A (ko) | 1995-02-20 |
| FI944655A0 (fi) | 1994-10-05 |
| EP0635009A1 (en) | 1995-01-25 |
| ZA932327B (en) | 1993-10-18 |
| WO1993020057A1 (en) | 1993-10-14 |
| DK0635009T3 (da) | 1997-10-06 |
| IL105318A0 (en) | 1993-08-18 |
| NZ251134A (en) | 1997-06-24 |
| DE69314022T2 (de) | 1998-02-12 |
| CA2132829C (en) | 1999-01-26 |
| NO943726D0 (no) | 1994-10-05 |
| JPH08503922A (ja) | 1996-04-30 |
| AU3797693A (en) | 1993-11-08 |
| DE69314022D1 (de) | 1997-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5380724A (en) | Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing same | |
| US5395834A (en) | New benzopyran compounds | |
| CZ374692A3 (en) | Proteolytic enzymes inhibitors based on saccharin derivatives | |
| EP0635009B1 (en) | Novel derivatives of 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols | |
| US5179093A (en) | Quinoline-diones | |
| US5484810A (en) | Tissue protective tocopherol analogs | |
| US4997846A (en) | Novel benzopyranylpyrrolinone derivatives | |
| US5721233A (en) | Derivatives of 2,3-dihydro benzofuranols | |
| US5455267A (en) | Chromone derivative, and aldose reductase inhibitor comprising said compound as active component | |
| US5545660A (en) | Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans | |
| CA2132745C (en) | Novel cardioprotective agents | |
| EP0635011B1 (en) | Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans | |
| JPH02215778A (ja) | ３，４―ジヒドロ―２ｈ―ベンゾピラン誘導体及びその医薬用途 | |
| AU705004B2 (en) | 2,3-dihydro-benzofuranol derivatives and process for resolving the same | |
| US5072006A (en) | Novel benzopyranylpyrrolinone derivatives | |
| US5510373A (en) | Cardioprotective agents | |
| PH26915A (en) | Novel benzopyranylpyrrolinone derivatives and its process of preparation | |
| WO2002053157A1 (en) | Thiazolidine derivative | |
| JPH0699308B2 (ja) | ヒダントイン誘導体を有効成分とする循環器系疾患の予防及び治療剤並びに循環器系疾患と糖尿病合併症の同時的予防及び治療剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| RH1 | Patent not in force |